Head-to-head comparison
MyFastRx vs PeptidesRx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.
$169/mo sema · $249/mo tirz · Verified July 2026
Marked down on: States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
Desk Score
PeptidesRx is a Fort Worth, TX-based licensed telehealth platform offering physician-supervised compounded semaglutide, tirzepatide, and a broader prescription peptide menu.
From $169/mo (lowest dose rung) sema · From $309/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Smaller scale than Henry Meds or Hims
MyFastRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 66/100 (C) for PeptidesRx. PeptidesRx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
MyFastRx
78/100
C+
PeptidesRx
66/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | MyFastRx | PeptidesRx |
|---|---|---|
| Semaglutide | $169/mo$169/mo | From $169/molowest dose rung$169/mo (0.25 mg dose, compounded) |
| Tirzepatide | $249/mo$249/mo | From $309/molowest dose rung$309/mo (2.5 mg dose, compounded) |
| Coverage | All 50 states | Not listed on PeptidesRx's site (checked July 2026) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Cash-pay patients comfortable with 12-month upfront billing for the lowest compounded-GLP-1 monthly rate. | Patients prioritizing regulatory compliance in the compounded space. |
| Desk Score | 78/100C+ | 66/100C |
The verdict
Desk pick — MyFastRxMyFastRx takes this head-to-head with the higher Desk Score, 78/100 (C+) against 66/100 (C) for PeptidesRx. PeptidesRx still holds its ground where its strengths line up with yours.
Choose MyFastRx if…
Cash-pay patients comfortable with 12-month upfront billing for the lowest compounded-GLP-1 monthly rate.
$169/mo sema · $249/mo tirz · All 50 states
Choose PeptidesRx if…
Patients prioritizing regulatory compliance in the compounded space.
From $169/mo (lowest dose rung) sema · From $309/mo (lowest dose rung) tirz
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: MyFastRx · PeptidesRx.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs MyFastRx
- CoreAge Rx vs PeptidesRx
- MyFastRx vs Ondra Health
- Ondra Health vs PeptidesRx
- MyFastRx vs Trimi
- PeptidesRx vs Trimi
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.